Pancreatic Neuroendocrine Tumors (pNET)
6 clinical trials · Condition
◉ Watch Pancreatic Neuroendocrine Tumors (pNET)
| Record | Firm | Date |
|---|---|---|
| BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. (NCT01658436) | Novartis Pharmaceuticals | 2012-11-01 |
| Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors (NCT01628913) | Novartis Pharmaceuticals | 2012-10-01 |
Track Pancreatic Neuroendocrine Tumors (pNET) automatically
Every clearance here is in the API, with alerts when new ones post.